APO Research
Talk to an analyst

APO RESEARCH · REPORT

Targeting Small Molecule Tumor Drugs

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Targeting Small Molecule Tumor Drugs Industry Growth and Trends Forecast to 2032

2 January 2026111 pages

Choose your research edition.

Industry ResearchTargeting Small Molecule Tumor Drugs Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Targeting Small Molecule Tumor Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Targeting Small Molecule Tumor Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Targeting Small Molecule Tumor Drugs Market Outlook and Growth Opportunities 2026203 pages · $4,250 USDMarket Analysis & ForecastGlobal Targeting Small Molecule Tumor Drugs Market Analysis and Forecast 2026-2032203 pages · $4,950 USD

Market perspective

According to APO Research, the global Targeting Small Molecule Tumor Drugs market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Targeting Small Molecule Tumor Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Targeting Small Molecule Tumor Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Targeting Small Molecule Tumor Drugs is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Targeting Small Molecule Tumor Drugs market include Yao Pharma, CHIATAI Tianqing, Zelgen, Simcere, Eisai, CSPC, Novartis, Roche and Jiangxi Shanxiang, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Targeting Small Molecule Tumor Drugs market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Targeting Small Molecule Tumor Drugs market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Targeting Small Molecule Tumor Drugs market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Targeting Small Molecule Tumor Drugs.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Targeting Small Molecule Tumor Drugs market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Targeting Small Molecule Tumor Drugs Market by Company

Yao Pharma

CHIATAI Tianqing

Zelgen

Simcere

Eisai

CSPC

Novartis

Roche

Jiangxi Shanxiang

Pfizer

BEACON Pharma

Bayer

AstraZeneca

Natco Pharma

Cipla

Bristol-Myers Squibb

Targeting Small Molecule Tumor Drugs Segment by Type

Alectinib

Anlotinib

Osimertinib

Lenvatinib

Regorafenib

Sorafenib

Other

Targeting Small Molecule Tumor Drugs Segment by Application

Hospital

Clinic

Other

Targeting Small Molecule Tumor Drugs Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Targeting Small Molecule Tumor Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Targeting Small Molecule Tumor Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Targeting Small Molecule Tumor Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Targeting Small Molecule Tumor Drugs companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Targeting Small Molecule Tumor Drugs Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Targeting Small Molecule Tumor Drugs Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Targeting Small Molecule Tumor Drugs Market Share by Region (2021-2026) Table 4. Global Targeting Small Molecule Tumor Drugs Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Targeting Small Molecule Tumor Drugs Market Share by Region (2027-2032) Table 6. Global Targeting Small Molecule Tumor Drugs Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Targeting Small Molecule Tumor Drugs Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Targeting Small Molecule Tumor Drugs Market Size Share by Type (2021-2026) Table 9. Global Targeting Small Molecule Tumor Drugs Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Targeting Small Molecule Tumor Drugs Market Size Share Forecasted by Type (2027-2032) Table 11. North America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Targeting Small Molecule Tumor Drugs Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Targeting Small Molecule Tumor Drugs Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Targeting Small Molecule Tumor Drugs Market Size Share by Application (2021-2026) Table 24. Global Targeting Small Molecule Tumor Drugs Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Targeting Small Molecule Tumor Drugs Market Size Share Forecasted by Application (2027-2032) Table 26. North America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Targeting Small Molecule Tumor Drugs Industry Trends Table 37. Targeting Small Molecule Tumor Drugs Industry Drivers Table 38. Targeting Small Molecule Tumor Drugs Industry Opportunities and Challenges Table 39. Targeting Small Molecule Tumor Drugs Industry Restraints Table 40. Global Targeting Small Molecule Tumor Drugs Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Targeting Small Molecule Tumor Drugs Revenue Market Share by Company (2021-2026) Table 42. Global Targeting Small Molecule Tumor Drugs Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Targeting Small Molecule Tumor Drugs Key Company Headquarters & Area Served Table 44. Global Targeting Small Molecule Tumor Drugs Company, Product Type & Application Table 45. Global Targeting Small Molecule Tumor Drugs Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Targeting Small Molecule Tumor Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Yao Pharma Company Information Table 49. Yao Pharma Business Overview Table 50. Yao Pharma Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Yao Pharma Targeting Small Molecule Tumor Drugs Product Portfolio Table 52. Yao Pharma Recent Development Table 53. CHIATAI Tianqing Company Information Table 54. CHIATAI Tianqing Business Overview Table 55. CHIATAI Tianqing Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. CHIATAI Tianqing Targeting Small Molecule Tumor Drugs Product Portfolio Table 57. CHIATAI Tianqing Recent Development Table 58. Zelgen Company Information Table 59. Zelgen Business Overview Table 60. Zelgen Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. Zelgen Targeting Small Molecule Tumor Drugs Product Portfolio Table 62. Zelgen Recent Development Table 63. Simcere Company Information Table 64. Simcere Business Overview Table 65. Simcere Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Simcere Targeting Small Molecule Tumor Drugs Product Portfolio Table 67. Simcere Recent Development Table 68. Eisai Company Information Table 69. Eisai Business Overview Table 70. Eisai Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Eisai Targeting Small Molecule Tumor Drugs Product Portfolio Table 72. Eisai Recent Development Table 73. CSPC Company Information Table 74. CSPC Business Overview Table 75. CSPC Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. CSPC Targeting Small Molecule Tumor Drugs Product Portfolio Table 77. CSPC Recent Development Table 78. Novartis Company Information Table 79. Novartis Business Overview Table 80. Novartis Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. Novartis Targeting Small Molecule Tumor Drugs Product Portfolio Table 82. Novartis Recent Development Table 83. Roche Company Information Table 84. Roche Business Overview Table 85. Roche Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Roche Targeting Small Molecule Tumor Drugs Product Portfolio Table 87. Roche Recent Development Table 88. Jiangxi Shanxiang Company Information Table 89. Jiangxi Shanxiang Business Overview Table 90. Jiangxi Shanxiang Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 91. Jiangxi Shanxiang Targeting Small Molecule Tumor Drugs Product Portfolio Table 92. Jiangxi Shanxiang Recent Development Table 93. Pfizer Company Information Table 94. Pfizer Business Overview Table 95. Pfizer Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 96. Pfizer Targeting Small Molecule Tumor Drugs Product Portfolio Table 97. Pfizer Recent Development Table 98. BEACON Pharma Company Information Table 99. BEACON Pharma Business Overview Table 100. BEACON Pharma Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 101. BEACON Pharma Targeting Small Molecule Tumor Drugs Product Portfolio Table 102. BEACON Pharma Recent Development Table 103. Bayer Company Information Table 104. Bayer Business Overview Table 105. Bayer Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 106. Bayer Targeting Small Molecule Tumor Drugs Product Portfolio Table 107. Bayer Recent Development Table 108. AstraZeneca Company Information Table 109. AstraZeneca Business Overview Table 110. AstraZeneca Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 111. AstraZeneca Targeting Small Molecule Tumor Drugs Product Portfolio Table 112. AstraZeneca Recent Development Table 113. Natco Pharma Company Information Table 114. Natco Pharma Business Overview Table 115. Natco Pharma Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 116. Natco Pharma Targeting Small Molecule Tumor Drugs Product Portfolio Table 117. Natco Pharma Recent Development Table 118. Cipla Company Information Table 119. Cipla Business Overview Table 120. Cipla Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 121. Cipla Targeting Small Molecule Tumor Drugs Product Portfolio Table 122. Cipla Recent Development Table 123. Bristol-Myers Squibb Company Information Table 124. Bristol-Myers Squibb Business Overview Table 125. Bristol-Myers Squibb Targeting Small Molecule Tumor Drugs Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 126. Bristol-Myers Squibb Targeting Small Molecule Tumor Drugs Product Portfolio Table 127. Bristol-Myers Squibb Recent Development Table 128. North America Targeting Small Molecule Tumor Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 129. North America Targeting Small Molecule Tumor Drugs Market Size by Country (2021-2026) & (US$ Million) Table 130. North America Targeting Small Molecule Tumor Drugs Market Share by Country (2021-2026) Table 131. North America Targeting Small Molecule Tumor Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 132. North America Targeting Small Molecule Tumor Drugs Market Share Forecast by Country (2027-2032) Table 133. Europe Targeting Small Molecule Tumor Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 134. Europe Targeting Small Molecule Tumor Drugs Market Size by Country (2021-2026) & (US$ Million) Table 135. Europe Targeting Small Molecule Tumor Drugs Market Share by Country (2021-2026) Table 136. Europe Targeting Small Molecule Tumor Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 137. Europe Targeting Small Molecule Tumor Drugs Market Share Forecast by Country (2027-2032) Table 138. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 139. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size by Country (2021-2026) & (US$ Million) Table 140. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Share by Country (2021-2026) Table 141. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 142. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Share Forecast by Country (2027-2032) Table 143. Latin America Targeting Small Molecule Tumor Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 144. Latin America Targeting Small Molecule Tumor Drugs Market Size by Country (2021-2026) & (US$ Million) Table 145. Latin America Targeting Small Molecule Tumor Drugs Market Share by Country (2021-2026) Table 146. Latin America Targeting Small Molecule Tumor Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 147. Latin America Targeting Small Molecule Tumor Drugs Market Share Forecast by Country (2027-2032) Table 148. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 149. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Country (2021-2026) & (US$ Million) Table 150. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Share by Country (2021-2026) Table 151. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Forecast by Country (2027-2032) & (US$ Million) Table 152. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Share Forecast by Country (2027-2032) Table 153. Research Programs/Design for This Report Table 154. Authors List of This Report Table 155. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Targeting Small Molecule Tumor Drugs Product Image Figure 3. Global Targeting Small Molecule Tumor Drugs Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Targeting Small Molecule Tumor Drugs Market Size (2021-2032) & (US$ Million) Figure 5. Global Targeting Small Molecule Tumor Drugs Market Share by Region: 2025 VS 2032 Figure 6. Global Targeting Small Molecule Tumor Drugs Market Share by Region (2021-2032) Figure 7. North America Targeting Small Molecule Tumor Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Targeting Small Molecule Tumor Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Targeting Small Molecule Tumor Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. Alectinib Image Figure 13. Global Alectinib Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. Anlotinib Image Figure 15. Global Anlotinib Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Osimertinib Image Figure 17. Global Osimertinib Market Size YoY Growth (2021-2032) & (US$ Million) Figure 18. Lenvatinib Image Figure 19. Global Lenvatinib Market Size YoY Growth (2021-2032) & (US$ Million) Figure 20. Regorafenib Image Figure 21. Global Regorafenib Market Size YoY Growth (2021-2032) & (US$ Million) Figure 22. Sorafenib Image Figure 23. Global Sorafenib Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. Other Image Figure 25. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Global Targeting Small Molecule Tumor Drugs Market Size Overview by Type (2021-2032) & (US$ Million) Figure 27. Global Targeting Small Molecule Tumor Drugs Market Share by Type 2025 VS 2032 Figure 28. North America Targeting Small Molecule Tumor Drugs Market Size Share by Type (2021-2032) Figure 29. Europe Targeting Small Molecule Tumor Drugs Market Size Share by Type (2021-2032) Figure 30. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Share by Type (2021-2032) Figure 31. Latin America Targeting Small Molecule Tumor Drugs Market Size Share by Type (2021-2032) Figure 32. Middle East and Africa Targeting Small Molecule Tumor Drugs Market Size Share by Type (2021-2032) Figure 33. Hospital Image Figure 34. Global Hospital Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Clinic Image Figure 36. Global Clinic Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Other Image Figure 38. Global Other Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Global Targeting Small Molecule Tumor Drugs Market Size Overview by Application (2021-2032) & (US$ Million) Figure 40. Global Targeting Small Molecule Tumor Drugs Market Share by Application 2025 VS 2032 Figure 41. North America Targeting Small Molecule Tumor Drugs Market Size Share by Application (2021-2032) Figure 42. Europe Targeting Small Molecule Tumor Drugs Market Size Share by Application (2021-2032) Figure 43. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Share by Application (2021-2032) Figure 44. Latin America Targeting Small Molecule Tumor Drugs Market Size Share by Application (2021-2032) Figure 45. Middle East and Africa Targeting Small Molecule Tumor Drugs Market Size Share by Application (2021-2032) Figure 46. Global Top 5 and 10 Targeting Small Molecule Tumor Drugs Players Market Share by Revenue in 2025 Figure 47. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 48. North America Targeting Small Molecule Tumor Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. North America Targeting Small Molecule Tumor Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. North America Targeting Small Molecule Tumor Drugs Market Share by Country (2021-2032) Figure 51. Europe Targeting Small Molecule Tumor Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Targeting Small Molecule Tumor Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Europe Targeting Small Molecule Tumor Drugs Market Share by Country (2021-2032) Figure 54. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Asia-Pacific Targeting Small Molecule Tumor Drugs Market Share by Country (2021-2032) Figure 57. Latin America Targeting Small Molecule Tumor Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Targeting Small Molecule Tumor Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Targeting Small Molecule Tumor Drugs Market Share by Country (2021-2032) Figure 60. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 61. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Share by Country: 2021 VS 2025 VS 2032 Figure 62. Middle East & Africa Targeting Small Molecule Tumor Drugs Market Share by Country (2021-2032) Figure 63. Years Considered Figure 64. Research Process Figure 65. Key Executives Interviewed

Scope & coverage.

Types
  • Alectinib
  • Anlotinib
  • Osimertinib
  • Lenvatinib
  • Regorafenib
  • Sorafenib
  • Other
Applications
  • Hospital
  • Clinic
  • Other
Companies covered
  • Yao Pharma
  • CHIATAI Tianqing
  • Zelgen
  • Simcere
  • Eisai
  • CSPC
  • Novartis
  • Roche
  • Jiangxi Shanxiang
  • Pfizer
  • BEACON Pharma
  • Bayer
  • AstraZeneca
  • Natco Pharma
  • Cipla
  • Bristol-Myers Squibb

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Targeting Small Molecule Tumor Drugs Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Targeting Small Molecule Tumor Drugs Market Size by Region (2021-2032)
  5. 1.4.1 Global Targeting Small Molecule Tumor Drugs Market Size by Region (2021-2026)
  6. 1.4.2 Global Targeting Small Molecule Tumor Drugs Market Size by Region (2027-2032)
  7. 1.5 Key Regions Targeting Small Molecule Tumor Drugs Market Size (2021-2032)
  8. 1.5.1 North America Targeting Small Molecule Tumor Drugs Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Targeting Small Molecule Tumor Drugs Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Targeting Small Molecule Tumor Drugs Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Growth Rate (2021-2032)
2 Targeting Small Molecule Tumor Drugs Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 Alectinib
  3. 2.1.2 Anlotinib
  4. 2.1.3 Osimertinib
  5. 2.1.4 Lenvatinib
  6. 2.1.5 Regorafenib
  7. 2.1.6 Sorafenib
  8. 2.1.7 Other
  9. 2.2 Global Targeting Small Molecule Tumor Drugs Market Size by Type
  10. 2.2.1 Global Targeting Small Molecule Tumor Drugs Market Size Overview by Type (2021-2032)
  11. 2.2.2 Global Targeting Small Molecule Tumor Drugs Historic Market Size Review by Type (2021-2026)
  12. 2.2.3 Global Targeting Small Molecule Tumor Drugs Market Size Forecasted by Type (2027-2032)
  13. 2.3 Global Targeting Small Molecule Tumor Drugs Market Size by Regions
  14. 2.3.1 North America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2021-2026)
  15. 2.3.2 Europe Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2021-2026)
  16. 2.3.3 Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2021-2026)
  17. 2.3.4 South America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2021-2026)
  18. 2.3.5 Middle East and Africa Targeting Small Molecule Tumor Drugs Market Size Breakdown by Type (2021-2026)
3 Targeting Small Molecule Tumor Drugs Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 Hospital
  3. 3.1.2 Clinic
  4. 3.1.3 Other
  5. 3.2 Global Targeting Small Molecule Tumor Drugs Market Size by Application
  6. 3.2.1 Global Targeting Small Molecule Tumor Drugs Market Size Overview by Application (2021-2032)
  7. 3.2.2 Global Targeting Small Molecule Tumor Drugs Historic Market Size Review by Application (2021-2026)
  8. 3.2.3 Global Targeting Small Molecule Tumor Drugs Market Size Forecasted by Application (2027-2032)
  9. 3.3 Global Targeting Small Molecule Tumor Drugs Market Size by Regions
  10. 3.3.1 North America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2021-2026)
  11. 3.3.2 Europe Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2021-2026)
  12. 3.3.3 Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2021-2026)
  13. 3.3.4 South America Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2021-2026)
  14. 3.3.5 Middle East and Africa Targeting Small Molecule Tumor Drugs Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Targeting Small Molecule Tumor Drugs Industry Trends
  2. 4.2 Targeting Small Molecule Tumor Drugs Industry Drivers
  3. 4.3 Targeting Small Molecule Tumor Drugs Industry Opportunities and Challenges
  4. 4.4 Targeting Small Molecule Tumor Drugs Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Targeting Small Molecule Tumor Drugs Revenue (2021-2026)
  2. 5.2 Global Targeting Small Molecule Tumor Drugs Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Targeting Small Molecule Tumor Drugs Key Company Headquarters & Area Served
  4. 5.4 Global Targeting Small Molecule Tumor Drugs Company, Product Type & Application
  5. 5.5 Global Targeting Small Molecule Tumor Drugs Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Targeting Small Molecule Tumor Drugs Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Targeting Small Molecule Tumor Drugs Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Targeting Small Molecule Tumor Drugs Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Yao Pharma
  2. 6.1.1 Yao Pharma Company Information
  3. 6.1.2 Yao Pharma Business Overview
  4. 6.1.3 Yao Pharma Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Yao Pharma Targeting Small Molecule Tumor Drugs Product Portfolio
  6. 6.1.5 Yao Pharma Recent Developments
  7. 6.2 CHIATAI Tianqing
  8. 6.2.1 CHIATAI Tianqing Company Information
  9. 6.2.2 CHIATAI Tianqing Business Overview
  10. 6.2.3 CHIATAI Tianqing Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 CHIATAI Tianqing Targeting Small Molecule Tumor Drugs Product Portfolio
  12. 6.2.5 CHIATAI Tianqing Recent Developments
  13. 6.3 Zelgen
  14. 6.3.1 Zelgen Company Information
  15. 6.3.2 Zelgen Business Overview
  16. 6.3.3 Zelgen Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 Zelgen Targeting Small Molecule Tumor Drugs Product Portfolio
  18. 6.3.5 Zelgen Recent Developments
  19. 6.4 Simcere
  20. 6.4.1 Simcere Company Information
  21. 6.4.2 Simcere Business Overview
  22. 6.4.3 Simcere Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Simcere Targeting Small Molecule Tumor Drugs Product Portfolio
  24. 6.4.5 Simcere Recent Developments
  25. 6.5 Eisai
  26. 6.5.1 Eisai Company Information
  27. 6.5.2 Eisai Business Overview
  28. 6.5.3 Eisai Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Eisai Targeting Small Molecule Tumor Drugs Product Portfolio
  30. 6.5.5 Eisai Recent Developments
  31. 6.6 CSPC
  32. 6.6.1 CSPC Company Information
  33. 6.6.2 CSPC Business Overview
  34. 6.6.3 CSPC Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 CSPC Targeting Small Molecule Tumor Drugs Product Portfolio
  36. 6.6.5 CSPC Recent Developments
  37. 6.7 Novartis
  38. 6.7.1 Novartis Company Information
  39. 6.7.2 Novartis Business Overview
  40. 6.7.3 Novartis Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 Novartis Targeting Small Molecule Tumor Drugs Product Portfolio
  42. 6.7.5 Novartis Recent Developments
  43. 6.8 Roche
  44. 6.8.1 Roche Company Information
  45. 6.8.2 Roche Business Overview
  46. 6.8.3 Roche Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Roche Targeting Small Molecule Tumor Drugs Product Portfolio
  48. 6.8.5 Roche Recent Developments
  49. 6.9 Jiangxi Shanxiang
  50. 6.9.1 Jiangxi Shanxiang Company Information
  51. 6.9.2 Jiangxi Shanxiang Business Overview
  52. 6.9.3 Jiangxi Shanxiang Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  53. 6.9.4 Jiangxi Shanxiang Targeting Small Molecule Tumor Drugs Product Portfolio
  54. 6.9.5 Jiangxi Shanxiang Recent Developments
  55. 6.10 Pfizer
  56. 6.10.1 Pfizer Company Information
  57. 6.10.2 Pfizer Business Overview
  58. 6.10.3 Pfizer Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  59. 6.10.4 Pfizer Targeting Small Molecule Tumor Drugs Product Portfolio
  60. 6.10.5 Pfizer Recent Developments
  61. 6.11 BEACON Pharma
  62. 6.11.1 BEACON Pharma Company Information
  63. 6.11.2 BEACON Pharma Business Overview
  64. 6.11.3 BEACON Pharma Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  65. 6.11.4 BEACON Pharma Targeting Small Molecule Tumor Drugs Product Portfolio
  66. 6.11.5 BEACON Pharma Recent Developments
  67. 6.12 Bayer
  68. 6.12.1 Bayer Company Information
  69. 6.12.2 Bayer Business Overview
  70. 6.12.3 Bayer Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  71. 6.12.4 Bayer Targeting Small Molecule Tumor Drugs Product Portfolio
  72. 6.12.5 Bayer Recent Developments
  73. 6.13 AstraZeneca
  74. 6.13.1 AstraZeneca Company Information
  75. 6.13.2 AstraZeneca Business Overview
  76. 6.13.3 AstraZeneca Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  77. 6.13.4 AstraZeneca Targeting Small Molecule Tumor Drugs Product Portfolio
  78. 6.13.5 AstraZeneca Recent Developments
  79. 6.14 Natco Pharma
  80. 6.14.1 Natco Pharma Company Information
  81. 6.14.2 Natco Pharma Business Overview
  82. 6.14.3 Natco Pharma Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  83. 6.14.4 Natco Pharma Targeting Small Molecule Tumor Drugs Product Portfolio
  84. 6.14.5 Natco Pharma Recent Developments
  85. 6.15 Cipla
  86. 6.15.1 Cipla Company Information
  87. 6.15.2 Cipla Business Overview
  88. 6.15.3 Cipla Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  89. 6.15.4 Cipla Targeting Small Molecule Tumor Drugs Product Portfolio
  90. 6.15.5 Cipla Recent Developments
  91. 6.16 Bristol-Myers Squibb
  92. 6.16.1 Bristol-Myers Squibb Company Information
  93. 6.16.2 Bristol-Myers Squibb Business Overview
  94. 6.16.3 Bristol-Myers Squibb Targeting Small Molecule Tumor Drugs Revenue, Global Share and Gross Margin (2021-2026)
  95. 6.16.4 Bristol-Myers Squibb Targeting Small Molecule Tumor Drugs Product Portfolio
  96. 6.16.5 Bristol-Myers Squibb Recent Developments
7 North America
  1. 7.1 North America Targeting Small Molecule Tumor Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Targeting Small Molecule Tumor Drugs Market Size by Country (2021-2026)
  3. 7.3 North America Targeting Small Molecule Tumor Drugs Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Targeting Small Molecule Tumor Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Targeting Small Molecule Tumor Drugs Market Size by Country (2021-2026)
  3. 8.3 Europe Targeting Small Molecule Tumor Drugs Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Targeting Small Molecule Tumor Drugs Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Targeting Small Molecule Tumor Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Targeting Small Molecule Tumor Drugs Market Size by Country (2021-2026)
  3. 10.3 South America Targeting Small Molecule Tumor Drugs Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Targeting Small Molecule Tumor Drugs Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst